H
H V Anderson
Researcher at The Texas Heart Institute
Publications - 10
Citations - 655
H V Anderson is an academic researcher from The Texas Heart Institute. The author has contributed to research in topics: Myocardial infarction & Artery. The author has an hindex of 6, co-authored 10 publications receiving 644 citations.
Papers
More filters
Journal ArticleDOI
Endogenous nitric oxide protects against platelet aggregation and cyclic flow variations in stenosed and endothelium-injured arteries.
Sheng-Kun Yao,Ober Jc,A Krishnaswami,James J. Ferguson,H V Anderson,Golino P,L M Buja,James T. Willerson +7 more
TL;DR: Test the hypothesis that endogenously produced nitric oxide protects against platelet aggregation and cyclic flow variations in stenosed and endothelium-injured arteries of mongrel dogs found it to be true, in both in vitro and ex vivo platelet studies.
Journal ArticleDOI
Frequency and severity of cyclic flow alternations and platelet aggregation predict the severity of neointimal proliferation following experimental coronary stenosis and endothelial injury.
James T. Willerson,Sheng-Kun Yao,Janice McNatt,Claude R. Benedict,H V Anderson,Paolo Golino,Sidney Murphree,L M Buja +7 more
TL;DR: In this paper, the role of recurrent platelet aggregation in the development of neointimal proliferation of coronary arteries was explored in 24 chronically instrumented dogs, and variable degrees of coronary artery proliferation were observed 3 weeks after mechanical injury of the arterial endothelium and the placement of an external coronary artery constrictor.
Journal ArticleDOI
Differences between men and women in the management of unstable angina pectoris (the Guarantee Registry)
Benjamin M. Scirica,David J. Moliterno,Nathan R. Every,H V Anderson,Frank V. Aguirre,Christopher B. Granger,Costas T. Lambrew,LeRoy E. Rabbani,Anita Arnold,Shelly Sapp,Joan E. Booth,James J. Ferguson,Christopher P. Cannon +12 more
TL;DR: Women and men with unstable angina admitted to 35 hospitals in the United States in 1996 had similar outcomes, despite different epidemiologic profiles and less evidence of coronary artery disease by noninvasive and invasive tests.
Evaluation of Ketanserin in the Prevention of Restenosis After Percutaneous Transluminal Coronary Angioplasty
Patrick Serruys,Werner Klein,Jan Tijssen,Wolfgang Rutsch,Guy R. Heyndrickx,Hakan Emanuelsson,Sarah Ball,O. Decoster,E. Schoeder,Henry A. Liberman,Edwin Eichhorn,James T. Willerson,H V Anderson,F. Khaja,R.W. Alexander,Donald S. Baim,Rein Melkert,J.C. van Oene,R. van Gool +18 more
TL;DR: Ketanserin at the dose administered in this trial failed to reduce the loss in minimal lumen diameter during follow-up after PTCA and did not significantly improve the clinical outcome.
Journal ArticleDOI
Combination of inhibition of thrombin and blockade of thromboxane A2 synthetase and receptors enhances thrombolysis and delays reocclusion in canine coronary arteries.
Sheng Kun Yao,Ober Jc,James J. Ferguson,H V Anderson,John Maraganore,L M Buja,James T. Willerson +6 more
TL;DR: Inhibition of thrombin in addition to treatment with t-PA enhances thrombolysis and delays or may prevent reocclusion of the recanalized coronary arteries.